HOME >> BIOLOGY >> NEWS
Novel flu vaccine shows promise in mice

PHILADELPHIA - Globally, the influenza virus, or flu, is thought to cause between three and five million cases of severe illness and between 250,000 and 500,000 deaths annually, according to the World Health Organization. New strains of the virus emerge each year, so that the U.S. Centers for Disease Control and other public health services must produce and distribute a new vaccine against the new flu strains each year. And each year, people seeking to avoid a flu infection must arrange to receive a flu shot - rarely a pleasant experience - from their doctor or other health-care provider. Also, the effectiveness of the vaccine is known to decline in the elderly, a population for whom flu infections can be particularly dangerous.

A new prototype vaccine developed by researchers at The Wistar Institute, however, might be able to protect recipients not only against this year's strains of the virus, but also against those yet to come, possibly eliminating the need for an annual shot. In fact, because the vaccine would be administered as a nasal spray, it could eliminate the need for a shot of any kind. A report on the new findings appears in the June 2 issue of the journal Vaccine.

"Current vaccines are quite effective, but they are based on regions of the virus that mutate rapidly, so health officials are constantly faced with the problem of updating the vaccines," says Walter Gerhard, M.D., senior author on the Vaccine report and a professor in the immunology program at The Wistar Institute. "A vaccine directed against a more stable region of the virus would offer important public-health advantages, and this is what we are hoping to be able to develop."

Current flu vaccines trigger an immune response to a pair of prominent viral-coat proteins that mutate constantly, which is the reason last year's flu vaccine is ineffective against this year's flu strains. The experimental vaccine contains an engineered peptide that mimics a third, smaller vira
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
27-May-2003


Page: 1 2 3

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician
11. Novel method identifies hidden genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... ... cell culture models into their drug discovery research workflows with biology ranging from ... in vivo relevancy of in vitro studies, they create several challenges that need ...
(Date:12/27/2018)... ... December 27, 2018 , ... uBiome, the leader in microbial ... JP Morgan 37th Annual Healthcare Conference in San Francisco, which brings together industry ... community. , Since its origin in 1983, the JP Morgan Healthcare Conference ...
(Date:12/20/2018)... TRIANGLE PARK, N.C. (PRWEB) , ... December 20, ... ... have been enhanced through upgraded processes and the completion of a new usability/observation ... Evaluations with the goal of ensuring medical devices and drug delivery devices/combination products ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... 2018 , ... Microbial Discovery Group LLC (MDG) has expanded ... of their strategic plan and an important milestone in increasing their Bacillus fermentation ... MDG within the $44 Billion human probiotic market. This plan is a vital ...
(Date:12/5/2018)... ZOETERMEER, Netherlands (PRWEB) , ... December 05, 2018 , ... ... last week paid tribute to in the European Parliament by Carlos Moedas, the European ... High-Level Conference EU Research and Innovation in Our Daily Lives, Commissioner Moedas spoke at ...
(Date:11/29/2018)... ... ... RAGS, today announced the closing of a $1.5 million Second Seed round investment. ... board member Jeremy Andrus, CEO of Traeger Grills, as well as James Ho of ... to accelerate its growth and expand the product line. RAGS has now raised a ...
(Date:11/26/2018)... ... 2018 , ... USARAD Holdings Inc., the leading US Joint ... Radiologic founders) among other healthcare investors exhibits at the Radiological Society of North ... The company is proud to announce a 10 year anniversary since its formation ...
Breaking Biology Technology:
Cached News: